Real-time enrollment status for this eosinophilic asthma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:32 AM UTC
| NCT Number | NCT06750289 |
| Recruiting Status | Recruiting |
| Condition | Eosinophilic Asthma |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 34 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | May 13, 2026 (May 13, 2026) |
As of July 18, 2026: Clinical trial NCT06750289 is currently recruiting participants. This phase3 study for eosinophilic asthma is actively seeking new participants at 34 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06750289 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 34 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06750289 was last updated May 13, 2026 (May 13, 2026). HelloStudys verifies this status automatically.